Passage BIO (PASG) Assets (2019 - 2026)
Passage BIO's Assets was $25.18 million in Q2 2026, down 68.2% from $79.2 million a year earlier and down 31.0% from the prior quarter.
Powered by 
Analysis
Passage BIO (PASG) Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Assets at Passage BIO came in at $62.28 million, down 39.2% from FY2024.
- Assets has now declined for four consecutive years, with a five-year compound annual growth rate of -28.3% (FY2020 to FY2025).
- In earlier years, Assets was $102.41 million in FY2024 (-32.0%), $150.55 million in FY2023 (-38.2%), $243.55 million in FY2022 (-31.4%) and $355.08 million in FY2021 (+8.3%).
- The Q2 2026 figure marks the lowest quarterly Assets in data going back to Q4 2019.
- Compared with a year earlier, Assets has declined for 18 straight quarters, with an average decline of 42.5% over the last eight quarters.
- The best year-over-year quarter for Assets over five years was Q3 2021 (growth of 9.0%); the worst was Q2 2026 (a decline of 68.2%).
- Per Business Quant data, PASG's Assets in the three quarters before Q2 2026 was $36.46 million (Q1 2026), $62.28 million (Q4 2025) and $74.16 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 148.07 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 147.68 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 132.77 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 119.92 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 96.05 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 51.41 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 205.00 Bn |
| 10 | Passage BIO | 12.16 Mn | -111.84 Mn | - | 20.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 20.79 Mn |
| Jun 30, 2026 | 25.18 Mn |
| Mar 31, 2026 | 36.46 Mn |
| Dec 31, 2025 | 62.28 Mn |
| Sep 30, 2025 | 74.16 Mn |
| Jun 30, 2025 | 79.20 Mn |
| Mar 31, 2025 | 86.01 Mn |
| Dec 31, 2024 | 102.41 Mn |
| Sep 30, 2024 | 111.75 Mn |
| Jun 30, 2024 | 125.39 Mn |
| Mar 31, 2024 | 140.53 Mn |
| Dec 31, 2023 | 150.55 Mn |
| Sep 30, 2023 | 169.26 Mn |
| Jun 30, 2023 | 193.70 Mn |
| Mar 31, 2023 | 213.24 Mn |
| Dec 31, 2022 | 243.55 Mn |
| Sep 30, 2022 | 270.05 Mn |
| Jun 30, 2022 | 299.42 Mn |
| Mar 31, 2022 | 333.22 Mn |
| Dec 31, 2021 | 355.08 Mn |
API Access
Passage BIO Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=PASG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "PASG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=PASG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();